Evidence map›Paper›PMID 34228724›Full record

ArticlePloS one2021

Structural and functional diversity among Type III restriction-modification systems that confer host DNA protection via methylation of the N4 atom of cytosine.

Iain A Murray, Yvette A Luyten, Alexey Fomenkov, Nan Dai, Ivan R Corrêa, William G Farmerie, Tyson A Clark, Jonas Korlach, Richard D Morgan, Richard J Roberts

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. i4mC-GRU: Identifying DNA NComputational and structural biotechnology journal · 2023
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Iain A MurrayNew England Biolabs, Ipswich, Massachusetts, United States of America.ORCID 0000-0002-6374-2461
Yvette A LuytenNew England Biolabs, Ipswich, Massachusetts, United States of America.
Alexey FomenkovNew England Biolabs, Ipswich, Massachusetts, United States of America.ORCID 0000-0002-2463-5946
Nan DaiNew England Biolabs, Ipswich, Massachusetts, United States of America.
Ivan R CorrêaNew England Biolabs, Ipswich, Massachusetts, United States of America.ORCID 0000-0002-3169-6878
William G FarmerieInterdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, Florida, United States of America.
Tyson A ClarkPacific Biosciences Inc., Menlo Park, California, United States of America.ORCID 0000-0002-7779-3227
Jonas KorlachPacific Biosciences Inc., Menlo Park, California, United States of America.
Richard D MorganNew England Biolabs, Ipswich, Massachusetts, United States of America.
Richard J RobertsNew England Biolabs, Ipswich, Massachusetts, United States of America.ORCID 0000-0002-4348-0169

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a new subgroup of Type III Restriction-Modification systems that use m4C methylation for host protection. Recognition specificities for six such systems, each recognizing a novel motif, have been determined using single molecule real-time DNA sequencing. In contrast to all previously characterized Type III systems which modify adenine to m6A, protective methylation of the host genome in these new systems is achieved by the N4-methylation of a cytosine base in one strand of an asymmetric 4 to 6 base pair recognition motif. Type III systems are heterotrimeric enzyme complexes containing a single copy of an ATP-dependent restriction endonuclease-helicase (Res) and a dimeric DNA methyltransferase (Mod). The Type III Mods are beta-class amino-methyltransferases, examples of which form either N6-methyl adenine or N4-methyl cytosine in Type II RM systems. The Type III m4C Mod and Res proteins are diverged, suggesting ancient origin or that m4C modification has arisen from m6A MTases multiple times in diverged lineages. Two of the systems, from thermophilic organisms, required expression of both Mod and Res to efficiently methylate an E. coli host, unlike previous findings that Mod alone is proficient at modification, suggesting that the division of labor between protective methylation and restriction activities is atypical in these systems. Two of the characterized systems, and many homologous putative systems, appear to include a third protein; a conserved putative helicase/ATPase subunit of unknown function and located 5' of the mod gene. The function of this additional ATPase is not yet known, but close homologs co-localize with the typical Mod and Res genes in hundreds of putative Type III systems. Our findings demonstrate a rich diversity within Type III RM systems.

Indexed as

CytosineDNA MethylationDNADNA Modification MethylasesDNA Restriction EnzymesDNA Restriction-Modification EnzymesEscherichia coliEscherichia coli ProteinsGas Chromatography-Mass SpectrometrySequence AlignmentSequence Analysis, DNACytosineDNADNA Modification MethylasesDNA Restriction EnzymesDNA Restriction-Modification EnzymesEscherichia coli Proteins

Identifiers

PMID34228724
PMCPMC8259958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.